These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9527799)

  • 1. Pharmacokinetics and inflammatory fluid penetration of clinafloxacin.
    Wise R; Jones S; Das I; Andrews JM
    Antimicrob Agents Chemother; 1998 Feb; 42(2):428-30. PubMed ID: 9527799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose.
    Wise R; Andrews JM; Ashby JP; Marshall J
    J Antimicrob Chemother; 1999 Nov; 44(5):701-4. PubMed ID: 10552990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose pharmacokinetics and penetration of BMS 284756 into an inflammatory exudate.
    Wise R; Gee T; Marshall G; Andrews JM
    Antimicrob Agents Chemother; 2002 Jan; 46(1):242-4. PubMed ID: 11751144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tolerance and pharmacokinetics of clinafloxacin (CI-960) in healthy subjects.
    Bron NJ; Dorr MB; Mant TG; Webb CL; Vassos AB
    J Antimicrob Chemother; 1996 Dec; 38(6):1023-9. PubMed ID: 9023649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).
    Wise R; Mortiboy D; Child J; Andrews JM
    Antimicrob Agents Chemother; 1996 Jan; 40(1):47-9. PubMed ID: 8787877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and tissue penetration of the new fluoroquinolone grepafloxacin.
    Child J; Andrews JM; Wise R
    Antimicrob Agents Chemother; 1995 Feb; 39(2):513-5. PubMed ID: 7726523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and inflammatory fluid penetration of sparfloxacin.
    Johnson JH; Cooper MA; Andrews JM; Wise R
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2444-6. PubMed ID: 1336947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose.
    Gee T; Andrews JM; Ashby JP; Marshall G; Wise R
    J Antimicrob Chemother; 2001 Apr; 47(4):431-4. PubMed ID: 11266415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate.
    Zix JA; Geerdes-Fenge HF; Rau M; Vöckler J; Borner K; Koeppe P; Lode H
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1668-72. PubMed ID: 9257738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration.
    Wise R; Andrews JM; Marshall G; Hartman G
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1508-10. PubMed ID: 10348784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative pharmacokinetics of lomefloxacin and other fluoroquinolones].
    Iakovlev VP
    Antibiot Khimioter; 1998; 43(10):46-52. PubMed ID: 9825111
    [No Abstract]   [Full Text] [Related]  

  • 12. Tissue penetration and pharmacokinetics of lomefloxacin following multiple doses.
    Kavi J; Stone J; Andrews JM; Ashby JP; Wise R
    Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):168-70. PubMed ID: 2498102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and tissue penetration of rufloxacin, a long acting quinolone antimicrobial agent.
    Wise R; Johnson J; O'Sullivan N; Andrews JM; Imbimbo BP
    J Antimicrob Chemother; 1991 Dec; 28(6):905-9. PubMed ID: 1667783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects.
    Kozawa O; Uematsu T; Matsuno H; Niwa M; Nagashima S; Kanamaru M
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2824-8. PubMed ID: 9124849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High performance liquid chromatography and preliminary pharmacokinetics of rufloxacin and its metabolites N-desmethylrufloxacin and rufloxacinsulfoxide in plasma and urine of humans.
    Vree TB; van den Biggelaar-Martea M; Imbimbo BP
    Eur J Drug Metab Pharmacokinet; 1992; 17(1):45-9. PubMed ID: 1323466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and tissue penetration of orally administered lomefloxacin.
    Stone JW; Andrews JM; Ashby JP; Griggs D; Wise R
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1508-10. PubMed ID: 3190181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ranitidine on renal clearance of lomefloxacin.
    Sudoh T; Fujimura A; Harada K; Sunaga K; Ohmori M; Sakamoto K
    Eur J Clin Pharmacol; 1996; 51(1):95-8. PubMed ID: 8880059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of clinafloxacin after single and multiple doses.
    Randinitis EJ; Brodfuehrer JI; Eiseman I; Vassos AB
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2529-35. PubMed ID: 11502525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antacid medication on the pharmacokinetics of temafloxacin.
    Granneman GR; Stephan U; Birner B; Sörgel F; Mukherjee D
    Clin Pharmacokinet; 1992; 22 Suppl 1():83-9. PubMed ID: 1319875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sparfloxacin pharmacokinetics in healthy volunteers: the influence of acidification and alkalinization.
    Kamberi M; Kotegawa T; Tsutsumi K; Nakamura K; Nakano S
    Eur J Clin Pharmacol; 1998 Oct; 54(8):633-7. PubMed ID: 9860151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.